Fangyu Peng, M.D., Ph.D.

Fangyu Peng, M.D., is an Associate Professor of Radiology at UT Southwestern Medical Center and a member of its Nuclear Medicine Division. He also holds a secondary appointment in the Advanced Imaging Research Center. His clinical interests include general nuclear medicine, PET imaging, and computed tomography (CT), with a particular interest in oncology and neurology. 

Dr. Peng earned his medical degree at Jiangxi Medical College in Nanchang, China. He then earned a master’s degree in molecular virology at Chinese Academy of Preventive Medicine's Institute of Virology in Beijing. He earned a doctoral degree in microbiology and immunology at the University of South Florida College of Medicine in Tampa. He then completed a research fellowship program in hematopathology at Ball Memorial Hospital in Muncie, Indiana, before completing his residency in pathology at Upstate Medical University in Syracuse, New York. Dr. Peng then completed a residency in nuclear medicine at the University of Connecticut Health Center in Farmington, and in anatomic pathology at Hartford Hospital. He completed his formal training with a fellowship program in nuclear medicine and molecular imaging at the National Institutes of Health in Bethesda, Maryland.

Before being recruited in 2008 to Nuclear Medicine Division, Dr. Peng served as an Assistant Professor of Radiology and Pediatrics at Wayne State University School of Medicine in Detroit, Michigan.

At UT Southwestern, he troubleshoots and improves imaging protocols, and actively participates in educational endeavors, in addition to his regular clinical responsibilities.

Dr. Peng focuses his research on inherited and acquired copper metabolism disorders in Wilson’s disease, Alzheimer’s disease, and traumatic brain injury, and investigates molecular imaging and targeted radionuclide cancer therapy with copper radionuclides. His research has been published in more than 50 peer-reviewed publications. He also invented and received a patent for intracellular trapping of radionuclides by enzyme-mediated reduction.

Medical School

Jiangxi Medical College (1982)

Other Post Graduate Training

University of South Florida (1994)

Graduate School

University of South Florida (1994), Medical Microbiology & Immunology

Fellowship

Ball Memorial Hospital (1996), Hematopathology

Residency

SUNY Upstate Medical University (1998), Pathology

Residency

University of Connecticut Health Center (2000), Nuclear Medicine

Residency

Hartford Hospital (2002), Anatomic Pathology

Fellowship

Warren Grant Magnuson Clinical Center - NIH (2003), Nuclear Medicine

• Molecular imaging and targeted radionuclide cancer therapy with copper radionuclides
• Positron Emission Tomography of altered copper fluxes in Wilson's disease, Alzheimer's disease, and traumatic brain injury with copper-64 chloride

Featured Publications

FDG PET/CT findings and post-treatment changes of COVID-19 pneumonia in a patient with lymphoma: A case report.

Matsui J, Kandathil A, Peng F, Mol Clin Oncol 2022 Mar 16 3 56

Isolated Hepatic Metastasis of Prostate Cancer with Variable ¹⁸F-fluociclovine Uptake by PET/CT Imaging.

Sorra E, Aziz MU, Peng F, Nucl Med Mol Imaging 2020 Feb 54 1 53-57

Ectopic Thyroid Tissue in the Mediastinum Characterized by Histology and Functional Imaging with I-123 SPECT/CT.

Hummel J, Wachsmann J, Carrick K, Oz OK, Mathews D, Peng F Case Rep Radiol 2017 2017 9084207

Asymmetric radiotracer activity of enlarged cerebral spinal fluid space on radionuclide cisternography with SPET/CT.

Bulman JC, Wachsmann J, Peng F Hell J Nucl Med 2016 Nov

Immune-mediated Disease in Ipilimumab Immunotherapy of Melanoma with FDG PET-CT.

Wachsmann JW, Ganti R, Peng F Acad Radiol 2016 Nov

Detection of Widespread Metastasis in a Case of Aggressive Carcinoma Showing Thymuslike Differentiation (CASTLE Disease) Using 18F-FDG PET/CT.

Iyamu I, Wachsmann J, Truelson J, Mathews D, Peng F Clin Nucl Med 2015 Apr

Recent Advances in Cancer Imaging with ⁶⁴CuCl₂ PET/CT.

Peng F, Nucl Med Mol Imaging 2022 Apr 56 2 80-85

Reduction in Copper Uptake and Inhibition of Prostate Cancer Cell Proliferation by Novel Steroid-based Compounds.

Xie F, Peng F, Anticancer Res 2021 Dec 41 12 5953-5958

Alteration of Copper Fluxes in Brain Aging: A Longitudinal Study in Rodent Using 64CuCl2-PET/CT.

Peng F, Xie F, Muzik O Aging Dis 2018 Feb 9 1 109-118

Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.

Xie F, Peng F J. Alzheimers Dis. 2017 Jun

• Fellow
  American College of Nuclear Medicine (2019)
• Chief Resident in Nuclear Medicine
  University of Connecticut Health Center (1999-2000)

• International Society to Advance Alzheimer’s Research and Treatment (2016)
• American College of Nuclear Medicine (2014)
• American Board of Nuclear Medicine (2001)
• Society of Nuclear Medicine and Molecular Imaging (1998)